The cost-effectiveness of adjuvant chemotherapy for early breast cancer: A comparison of no chemotherapy and first, second, and third generation regimens for patients with differing prognoses.
about
Unremarked or Unperformed? Systematic Review on Reporting of Validation Efforts of Health Economic Decision Models in Seasonal Influenza and Early Breast CancerPreliminary Development and Evaluation of an Algorithm to Identify Breast Cancer Chemotherapy Toxicities Using Electronic Medical Records and Administrative Data.Optimal approach in early breast cancer: Radiation therapyClinical utility of the IHC4+C score in oestrogen receptor-positive early breast cancer: a prospective decision impact study.Cost-utility analyses of drug therapies in breast cancer: a systematic review.Adjuvant epirubicin followed by cyclophosphamide, methotrexate and fluorouracil (CMF) vs CMF in early breast cancer: results with over 7 years median follow-up from the randomised phase III NEAT/BR9601 trialsChanging case Order to Optimise patterns of Performance in mammography Screening (CO-OPS): study protocol for a randomized controlled trial.Health economic impact of risk group selection according to ASCO-recommended biomarkers uPA/PAI-1 in node-negative primary breast cancer.Personalized treatment of women with early breast cancer: a risk-group specific cost-effectiveness analysis of adjuvant chemotherapy accounting for companion prognostic tests OncotypeDX and Adjuvant!Online.
P2860
Q26748855-93570E7C-A950-4307-86A9-478F262CC97CQ30845285-F799AF19-A109-4C2A-B168-B097803E7BD8Q33699050-135F29A8-4FF5-4E31-83DB-6EB7CB6D7BA2Q35909626-33DE01F8-6911-4F8D-8544-F3C1171E19D1Q36116276-A1B5A9A2-8E54-4C84-8C8D-1CB77C06FAB3Q36387794-5D5DDFA3-5F66-4836-AB0F-2039CD671AFFQ37506850-2F9C667E-86C1-498B-9081-36C4B0BD96D0Q38316487-749295F6-0C42-4838-AB91-654E0613022EQ42690907-0CBD706A-DB23-4DB0-B41C-1FE6D9382650
P2860
The cost-effectiveness of adjuvant chemotherapy for early breast cancer: A comparison of no chemotherapy and first, second, and third generation regimens for patients with differing prognoses.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
The cost-effectiveness of adju ...... ents with differing prognoses.
@en
The cost-effectiveness of adju ...... ents with differing prognoses.
@nl
type
label
The cost-effectiveness of adju ...... ents with differing prognoses.
@en
The cost-effectiveness of adju ...... ents with differing prognoses.
@nl
prefLabel
The cost-effectiveness of adju ...... ents with differing prognoses.
@en
The cost-effectiveness of adju ...... ents with differing prognoses.
@nl
P2093
P1476
The cost-effectiveness of adju ...... ents with differing prognoses.
@en
P2093
D Bloomfield
H E Campbell
P304
P356
10.1016/J.EJCA.2011.06.019
P577
2011-07-07T00:00:00Z